Management tracks

Anemia and asthma play Pieris Pharmaceuticals Inc. (NASDAQ:PIRS) named Louis Matis SVP and chief development officer. Matis was executive director of strategic evaluation at Alexion Pharmaceuticals Inc. (NASDAQ:ALXN). ...